Anti-TNFα therapy may help reduce risk of developing Parkinson’s disease
Mount Sinai shows the potential link between Parkinson's disease and inflammatory bowel disease, suggests anti-TNFα therapy may reduce the risk of developing Parkinson's...
List view / Grid view
News
New vaccine could help people overcome cathinone abuse
Researchers have developed a vaccine for one of the most dangerous types of synthetic cathinones...
Improved method of delivering anti-cancer drugs
A new non-toxic method for delivering anti-cancer drugs to specific parts of the human body could mean the end of the severe side effects...
FDA approves first therapy for rare inherited form of rickets, x-linked hypophosphatemia
The FDA has approved Crysvita, the first drug approved to treat adults and children ages 1 year and older with x-linked hypophosphatemia, a rare, inherited form of rickets...
New C2MAP automated pretreatment module
Complete LC/MS solution for cell culture analysis...
KL1333 receives FDA ODD for mitochondrial diseases
NeuroVive Pharmaceutical AB has been granted Orphan Drug Designation for its project KL1333 for treatment of inherited mitochondrial respiratory chain diseases...
Delivering cancer treatment on a nanodisc helps eliminate tumours
Novel platform for chemo-immunotherapy eliminated colon cancer in 85 percent of treated mice...
Could statins ease deadly heart condition in rare neuromuscular disease?
Penn study shows that cholesterol drug may help Friedreich's ataxia patients...
Using AI to detect heart disease
Researchers apply machine learning to create a quick and easy method for measuring changes linked to cardiovascular disease...
Diabetes drug may not reduce risk of death
One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings...
Machine learning may reveal cause-effect relationships in protein dynamics data
A group of researchers is showing how artificial intelligence approaches can help identify cause-effect relationships within data...
Novartis invests $100 mn to eliminate malaria
Novartis is to invest more than $ 100 million to advance research and development of new antimalarials over the next five years...
FDA accepts NDA for ALKS 5461 for major depressive disorder
The FDA has accepted for review the New Drug Application for ALKS 5461, a novel, once-daily, oral investigational medicine for the adjunctive treatment of major depressive disorder ...
Painkillers in pregnancy may affect baby’s future fertility
Taking painkillers during pregnancy could affect the fertility of the unborn child in later life, research suggests...
Contrast-enhanced subharmonic imaging detects prostate cancers
A test of contrast-enhanced subharmonic imaging has shown promise in detecting prostate cancers that were not identified by MRI...
